MacroGenics, Inc.
- MGNX
- NASDAQ
- Biotechnology
- Antibody Therapeutics
- Oncology (Immuno-Oncology)
$3.25
Today −3.56%Quote Oct 16, 2026, 08:00 PM UTC
−21.31%over the last month
Max drawdown −21.5%From 1-month high −21.5%3 months −24.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$207.0M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$6.00
+84.6% from here
Floor
$3.22
0.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MGNXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
293
Founded
2000